Tuberculous Chorioretinitis.
Verhoeff FH.
Trans Am Ophthalmol Soc. 1931;29:417.
TUBERCULOUS CHORIORETINITIS: A CHALLENGING CASE OF AN OPHTHALMIC MIMIC.
Dedina L, Little M, Durkin S.
Retin Cases Brief Rep. 2023 Jul 1;17(4):430-432. doi: 10.1097/ICB.0000000000001212.
Tuberculous chorioretinitis.
Waheeb S, Al-Saadi M, Quinn AG, Buncic JR.
Can J Ophthalmol. 2001 Oct;36(6):344-6. doi: 10.1016/s0008-4182(01)80123-x.
Concurrent tuberculous chorioretinitis with choroidal neovascularization and tuberculous meningitis: a case report.
Zhang YK, Fu HY, Guan Y, Li YJ, Bai HZ.
BMC Ophthalmol. 2020 Jun 12;20(1):227. doi: 10.1186/s12886-020-01504-y.
HIV-induced Retinitis.
Wons J, Kempen J, Garweg JG.
Ocul Immunol Inflamm. 2020 Nov 16;28(8):1259-1268. doi: 10.1080/09273948.2020.1808225. Epub 2020 Sep 23.
Paradoxical worsening of tuberculous chorioretinitis in a Chinese gentleman.
Siantar RG, Ho SL, Agrawal R.
J Ophthalmic Inflamm Infect. 2015 Jul 9;5:21. doi: 10.1186/s12348-015-0052-1. eCollection 2015.
Clinical picture: tuberculous chorioretinitis.
Lanzafame M, Trevenzoli M, Vento S, Parrinello A.
Lancet. 2001 May 5;357(9266):1390. doi: 10.1016/s0140-6736(00)04622-5.
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial.
Nguyen QD, Merrill PT, Jaffe GJ, Dick AD, Kurup SK, Sheppard J, Schlaen A, Pavesio C, Cimino L, Van Calster J, Camez AA, Kwatra NV, Song AP, Kron M, Tari S, Brézin AP.
Lancet. 2016 Sep 17;388(10050):1183-92. doi: 10.1016/S0140-6736(16)31339-3. Epub 2016 Aug 16.
Inflammatory pseudohistoplasmosis.
Deutsch TA, Tessler HH.
Ann Ophthalmol. 1985 Aug;17(8):461-5.
White spots syndromes.
Verougstraete C.
Bull Soc Belge Ophtalmol. 2001;(279):67-78.
